Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven CancersVivek Subbiah, Erica Evans, Rami Rahal et al.|Cancer Discovery|2018Cited by 392
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling PathwayMargit Hagel, Timothy J. Guzi|Cancer Discovery|2015Cited by 314